课题基金 / 基金详情

A PHASE I EVALUATION OF TEMOZOLOMIDE IN PEDIATRIC PATIENTS WITH MALIGNANCIES

A PHASE I EVALUATION OF TEMOZOLOMIDE IN PEDIATRIC PATIENTS WITH MALIGNANCIES
替莫唑胺治疗儿科恶性肿瘤患者的 I 期评估
批准号：
5219311
负责人：
JULIE BLATT
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5219311
关键词：
child (0-11) clinical research clinical trial phase I dacarbazine drug administration rate /duration drug screening /evaluation human subject human therapy evaluation imidazole neoplasm /cancer chemotherapy neoplasm /cancer pharmacology oral administration pediatric neoplasm /cancer pediatric pharmacology pharmacokinetics

项目摘要

项目成果

JULIE BLATT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this study is to determine the maximal tolerated dose of oral temozolomide given daily for five days. The toxicities and pharmacokinetic behavior of this drug will also be studied using this schedule.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDY OF SELECTED LATE EFFECTS IN PATIENTS TREATED FOR NONHODGKINS LYMPHOMA
PEDIATRIC PHASE I TRIAL AND PHARMACOKINETIC STUDY OF LGC1057
PHASE I STUDY OF TOPOTECAN AND CISPLATIN IN THE TREATMENT OF SOLID TUMORS
THERAPEUTIC ROLE OF FERRITIN IN NEUROBLASTOMA
海外基金